UroGen Pharma Ltd.

NASDAQ: URGN · Real-Time Price · USD
19.74
-0.34 (-1.69%)
At close: Aug 15, 2025, 3:59 PM
19.50
-1.22%
After-hours: Aug 15, 2025, 06:59 PM EDT

UroGen Pharma Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-3.6 -4.23 -1.84 -1.92
PEG Ratio
0.22 0.16 0.54 0.12
PS Ratio
5.05 5.23 3.14 4.42
PB Ratio
-51.87 -6.63 -2.26 25.26
P/FCF Ratio
-4.7 -5.65 -2.3 -2.48
P/OCF Ratio
-4.72 -5.66 -2.31 -2.5
OCF/S Ratio
-1.07 -0.92 -1.36 -1.77
Debt / Equity Ratio
-14.02 -1.54 -1.12 0.05
Quick Ratio
5.81 5.24 5.21 4.90
Current Ratio
6.01 5.42 5.39 5.11
Asset Turnover
0.32 0.46 0.47 0.40
Interest Coverage
-7.73 -4.45 -9.37 -5.29
Return on Equity
14.41 1.57 1.23 -13.17
Return on Assets
-0.44 -0.57 -0.81 -0.93
Return on Invested Capital
-0.41 -0.46 -0.71 -0.93
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.90 0.89 0.88 0.89
Net Profit Margin
-1.4 -1.24 -1.71 -2.31
Pretax Profit Margin
-1.37 -1.19 -1.68 -2.28
Operating Profit Margin
-1.07 -0.79 -1.23 -1.92
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-1.22 -0.73 -1.18 -1.88